News
Displaying 131–140 of 541
-
Research News
Dr. Tucker is leading the development of GMP facilities for manufacturing clinical grade retinal therapies
-
Foundation News
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Statement from Jason Menzo about Lyft's Refusal to Accept Rider with Guide Dog.
Foundation NewsAs CEO of an organization committed to those impacted by vision loss, it is disheartening there is still discrimination against visually impaired riders who use ride-sharing apps like Uber and Lyft.
-
Research News
Clinical trial participants with advanced vision loss from RP were able to identify fruits and vegetables
-
Geographic Atrophy: The Advanced Form of Dry AMD
Research NewsGeographic atrophy causes significant central vision loss and remains an unmet medical need.
-
Research News
Most participants with advanced retinitis pigmentosa (RP) in the trial had improved navigation and/or object discrimination in reduced lighting conditions
-
Foundation News
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
RD Fund Appoints Mark S. Blumenkranz, MD, MMS to Board of Directors
In the PressOphthalmology visionary Mark S. Blumenkranz, MD, MMS, to join RD Fund’s Board.
-
Foundation Fighting Blindness to Host their Spring VisionWalks
Foundation NewsThese VisionWalk events taking place this spring will raise awareness and fund research finding treatments and cures for blinding retinal diseases.
-
Research News
Geographic atrophy (GA) is the advanced form of dry age-related macular degeneration (AMD) which causes blindness in one million people in the United States and 5 million worldwide.
This is the first time that a treatment has been approved for this leading cause of blindness.
